Skip to main content
Premium Trial:

Request an Annual Quote

Exelixis Delivers Targets to Dow AgroSciences

NEW YORK, Nov. 29 – Exelixis said Thursday it had delivered four crop protection targets to Dow AgroSciences under a collaboration deal signed one year ago.

Exelixis of South San Francisco used its Mechanism of Action technology to identify the molecular target of biologically active herbicide and fungicide compounds provided by Dow AgroSciences of Indianapolis. 

Exelixis will receive milestone payments as a result of the discovery. 

"We are eager to move these targets forward to the next phase of lead discovery," Dan Kittle, vice president of Ag Chem and Urban Pest R&D at Dow AgroSciences, said in a statement.

"Dow AgroSciences is confident that this collaboration will continue to efficiently identify high quality targets, which will enable us to speed the discovery and development of new fungicides and herbicides of value to agriculture," he said. 

Dow AgroSciences is a wholly owned subsidiary of the Dow Chemical Company.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.